Bioreactor

clean room facility, to allow adherence to strict manufacturing requirements (GMP) of therapeutic-grade cellular components. The acquisition also serves to ensure necessary clinical back-up, securing patient safety.

Equipment for clinical manufacturing of advanced cellular therapies under GMP requirements. The equipment facilitates semi-automated, closed system processing of cells for patient treatments. The system will be used in a